tenants

AbacusBio Ltd, international leaders in the application of science and technology in primary food production, building strong lasting relationships, by combining science and business expertise to grow clients’ revenue and profit. 

AbacusBio consultants moved in to our open-plan office space in August 2017 and from this UK base provide independent services and products to industry organisations, businesses, and investment groups.

The company's global reach gives the company a technical and strategic view of a wide range of challenges facing primary food production.

Argenta Ltd moved in to our open-plan office space in August 2018, complementing Argenta’s other global facilities, including recently acquired manufacturing facilities in Dundee, Scotland.

Argenta is the world’s only combined contract research organisation (CRO) and contract manufacturing organisation (CMO) specialising in animal health. With accredited operations and facilities across New Zealand, the United States of America and the United Kingdom, Argenta is fully equipped to offer a full range of products and services to the global animal health industry. 

Argenta’s 400+ global team develops and exports products and services to over 40 countries.

ARK Genomics Ltd (AGL) joined us from the start, occupying open plan office space. 

The company promotes genomic research, bringing together commercial companies and academia, and provides access to cutting edge sequencing technologies for human and animal health working with their partner Edinburgh Genomics.  

AGL is supported by Roslin Technologies and offers a dedicated project management service, supporting their clients at all stages of a project and alongside this can act as an opportune and strategic grant collaborator and partner. 

Thomas Farrugia of Beta Bugs was announced as a Royal Society of Edinburgh (RSE) Unlocking Ambition Enterprise Fellow in June 2018 following successful completion of the Unlocking Ambition Challenge. 

Beta Bugs accelerate insect evolution, creating new breeds of commercially farmed insects for the alternative protein industry and make them into next-gen crops that will drive a sustainable bio economy.

Roslin Innovation Centre is hosting the entrepreneurial start-up as part of this new programme supported by Scottish Government and RSE.

Ingenza Ltd, a spin-out from the University of Edinburgh founded in 2002, is led by a management team with over 25 years’ experience in applied bioscience and the development and commercialisation of biobased products.

Following the closure of the neighbouring Roslin BioCentre, Ingenza relocated to customised lab and office space at Roslin Innovation Centre at the end of July 2018. 

The company has integrated teams of scientists, bringing together expertise across synthetic chemistry, informatics, molecular genetics, biochemistry and fermentation scale-up. 

MV Diagnostics is a research and development company, focused on the development and provision of innovative immunoassays and reagents for use in clinical and research laboratories worldwide.

MV Diagnostics aims to deliver innovative technical solutions to diagnostic problems and supply high quality veterinary ELISA kits and recombinant proteins/peptides. These kits and testing services have been used in cattle, sheep, goats, alpacas, deer, badgers, wild boar, and a variety of Zoo species.

The company occupies open-plan office space with us and works with collaborators nationally and internationally, using their extensive experience to help resolve challenges in the diagnosis, control and eradication of animal diseases. 

Roslin Technologies Ltd is an agriculture biotechnology company and the commercialisation arm of the world renowned Roslin Institute and University of Edinburgh’s Royal (Dick) School of Veterinary Studies.

The company’s shareholders are the University of Edinburgh, the agriculture-focused private equity advisors JB Equity and the British Innovation Fund, which invests in leading British university innovation venture funds and companies.

We provide Roslin Technologies with open plan office space and facilities to associated project teams, such as Eggcellent Proteins, commercialising transgenic chicken bioreactor technology for production of valuable proteins.

Synpromics Ltd is one of the UK’s most innovative companies working in gene medicine and an ideal fit for our tenant profile. 

Synpromics is expanding to meet increasing global demand for its cutting-edge gene control technology. 

The company occupy customised lab and open plan office space with us to facilitate the development and commercialisation of synthetic promoters for gene and cell therapy products and bioprocess applications.

Tropical Animal Genetics Ltd (TAG) provides industry-leading reproductive technologies and expertise to meet the growing needs for having superior genetics for the farmers and breeders.

On-going research and applied science allows TAG to develop and implement new technologies that will help move the science of tropical animal genetic improvement forward.

We are pleased to provide open-plan office space to members of the TAG team.

We look forward to welcoming Cytochroma, producing a range of stem cell derived liver models and tailored toxicity testing to support a variety of life science companies in the acceleration of drug discovery, making new medicine development faster and safer.

Cytochroma, seeks to address the increasingly expensive but less effective practices of drug discovery through developing stable, scale-able, reliable, DILI predictive human liver cells in a fast, cheap and sensitive screening method, which will accurately identify toxicity. 

The company is led by Kate Cameron, a current BBSRC funded RSE Enterprise Fellow hosted by Edinburgh Innovations, and a recent winner of the Higgs EDGE prize for innovation in science and technology, securing the top award of £150,000.

Greengage Enlightened Farming joined us in our 'pop up incubator' space August 2015 and expanded their office space with an extra unit in March 2016 - we look forward to welcoming the team to Roslin Innovation Centre in October 2018.

Greengage delivers LED agricultural lighting, sensors and control systems for improved farming environments for poultry, pigs and cattle. 

Greengage is a leading global manufacturer of "ALIS" an LED (Light Emitting Diode) lighting and induction power system.

We look forward to welcoming N2 Pharmaceuticals Ltd, developers of a drug
N2-01, that is proven to dramatically increase the effectiveness of artificial insemination (“AI”) of dairy cattle. In the UK alone, low effectiveness of AI costs the industry £0.5bn per year and is described as a major problem in agriculture.

N2-01 is a unique medicine derived from extracts of Mytilus edulis (Blue mussels) and does not contain any hormones/antibiotics, which allows its usage in farms with strict ecological standards, as well as unrestricted use of milk/meat by humans.

Approved for registration and use in Russia, N2-01 has been widely tested and proved successful by practicing vets in commercial farms in Russia. N2 Pharmaceuticals is in the process of seeking regulatory approval for N2-01 in mainstream territories as a treatment to enhance the success rates of artificial insemination in dairy cattle.